中国全科医学
中國全科醫學
중국전과의학
CHINESE GENERAL PRACTICE
2014年
36期
4350-4352
,共3页
贝赫切特综合征%肿瘤坏死因子α%英夫利昔单抗
貝赫切特綜閤徵%腫瘤壞死因子α%英伕利昔單抗
패혁절특종합정%종류배사인자α%영부리석단항
Behcet syndrome%Tumor necrosis factor-alpha%Infliximab
白塞病又称贝赫切特病（ BD），是一种慢性全身性血管炎性疾病。白塞病常累及胃肠道，即肠白塞病，患者常出现胃肠道溃疡、出血、穿孔等。英夫利昔单抗（ IFX）是单克隆肿瘤坏死因子α（ TNF-α）拮抗剂，在多种炎性疾病中得到广泛应用。本文结合2例肠白塞病患者的诊治过程，分析IFX治疗肠白塞病的有效性和安全性。
白塞病又稱貝赫切特病（ BD），是一種慢性全身性血管炎性疾病。白塞病常纍及胃腸道，即腸白塞病，患者常齣現胃腸道潰瘍、齣血、穿孔等。英伕利昔單抗（ IFX）是單剋隆腫瘤壞死因子α（ TNF-α）拮抗劑，在多種炎性疾病中得到廣汎應用。本文結閤2例腸白塞病患者的診治過程，分析IFX治療腸白塞病的有效性和安全性。
백새병우칭패혁절특병（ BD），시일충만성전신성혈관염성질병。백새병상루급위장도，즉장백새병，환자상출현위장도궤양、출혈、천공등。영부리석단항（ IFX）시단극륭종류배사인자α（ TNF-α）길항제，재다충염성질병중득도엄범응용。본문결합2례장백새병환자적진치과정，분석IFX치료장백새병적유효성화안전성。
Behcet's disease( BD) is a kind of chronic systemic vascular inflammatory disease. BD often affects stom-ach and intestines tunnel, thus intestinal BD occurs, patients usually have gastrointestinal ulcers, bleeding and perfora-tion. Infliximab(IFX)is a monoclonal TNF -α antagonist,which is widely used to treat many kinds of inflammatory disea-ses. The diagnosis and treatment process of two patients with intestinal Behcet's disease is reviewed,the efficacy and safety of in-fliximab in treatment of intestinal Behcet's disease are analysed in the paper.
